Overweight and Obesity
771
85
130
492
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
55 trials with published results (7%)
Research Maturity
492 completed trials (64% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
20 terminated out of 771 trials
96.1%
+9.6% vs benchmark
2%
19 trials in Phase 3/4
11%
55 of 492 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 492 completed trials
Clinical Trials (771)
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial
Ketogenic Diet in Women With Lipedema
Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101
A Study to Evaluate the Adjustment Function of a Modified Spatz3 Adjustable Balloon (Spatz4).
Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus
WB-EMS Effects on Cardiometabolic Risk Factors
OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals
Healthy Gestational Weight Gain Programme
Online Dietary Weight Loss Program for Arab Adults: A Randomized Controlled Trial
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
Equal-Volume Pilates Frequency in Women With Overweight and Obesity
Glycemic Variability Comparing Two vs Five Meals in Type 2 Diabetes
Early vs. Late Time Restricted Eating vs. Daily Caloric Restriction
Maternal Betaine Supplementation During Breastfeeding
Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
Daily Self-Weighing for Obesity Management in Primary Care
A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations
Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia